Get a sharp perspective on the cell and gene status quo in The Medicine Maker 2022 supplement on advanced medicine

After years of progress in the courts, could one verdict in California give unproven stem cell clinics an unwelcome boost?

What did switching from client to constructor teach a seasoned biotech professional?

The Drugs for Neglected Diseases initiative has a new leader – and he’s on a mission to redefine global health for an egalitarian, postcolonial world

In 2014, the Ice Bucket Challenge raised millions; eight years on, we have an FDA-approved therapy

The founder a UK manufacturer that serves pharma explains why his company switched to a bottom-up model

From surge to stumble and back again, seven cell and gene legends recount their personal favorite breakthroughs in the field.

We speak to one of advanced therapy’s great minds about analog and digital events, and the future of the field.

Can AI usher in a new age of medicine or is it all hype? In this blog, we go down the rabbit hole.

We asked the field’s greatest minds: “What improvements do we need to see in cell and gene supply chains?”